Healthcare provider profile · identity verified

Lauren Catherine Abbate, MD

Internal Medicine · BOSTON, MA · NPI 1922099621

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	241	77
Omeprazole	Omeprazole	135	36
Metoprolol Succinate	Metoprolol Succinate	115	31
Atorvastatin Calcium	Atorvastatin Calcium	104	33
Amlodipine Besylate	Amlodipine Besylate	103	32
Lisinopril	Lisinopril	103	33
Jardiance	Empagliflozin	84	20
Gabapentin	Gabapentin	74	16
Lorazepam	Lorazepam	70	16
Losartan Potassium	Losartan Potassium	69	17
Levothyroxine Sodium	Levothyroxine Sodium	65	20
Hydrochlorothiazide	Hydrochlorothiazide	57	15
Fluticasone Propionate	Fluticasone Propionate	46	16
Ozempic	Semaglutide	45	suppressed
Irbesartan	Irbesartan	44	12
Tamsulosin Hcl	Tamsulosin Hcl	43	13
Zolpidem Tartrate	Zolpidem Tartrate	41	suppressed
Eliquis	Apixaban	40	suppressed
Clonazepam	Clonazepam	39	suppressed
Oxycodone Hcl	Oxycodone Hcl	38	suppressed
Tramadol Hcl	Tramadol Hcl	38	suppressed
Furosemide	Furosemide	37	13
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	35	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	34	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	33	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	31	suppressed
Pravastatin Sodium	Pravastatin Sodium	31	suppressed
Glipizide Er	Glipizide	30	suppressed
Ibuprofen	Ibuprofen	30	suppressed
Allopurinol	Allopurinol	29	suppressed
Alprazolam	Alprazolam	29	suppressed
Simvastatin	Simvastatin	28	suppressed
Ventolin Hfa	Albuterol Sulfate	28	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	27	12
Famotidine	Famotidine	26	suppressed
Potassium Chloride	Potassium Chloride	25	suppressed
Spironolactone	Spironolactone	25	suppressed
Lidocaine	Lidocaine	24	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	24	14
Wixela Inhub	Fluticasone Propion/Salmeterol	24	suppressed
Atenolol	Atenolol	22	suppressed
Bupropion Xl	Bupropion Hcl	22	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Montelukast Sodium	Montelukast Sodium	22	suppressed
Sertraline Hcl	Sertraline Hcl	22	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	20	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Metformin Hcl	Metformin Hcl	19	suppressed
Metformin Hcl Er	Metformin Hcl	19	suppressed
Trulicity	Dulaglutide	19	suppressed
Bumetanide	Bumetanide	18	suppressed
Duloxetine Hcl	Duloxetine Hcl	17	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	17	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	16	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	16	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	15	suppressed
Ondansetron Odt	Ondansetron	15	suppressed
Trazodone Hcl	Trazodone Hcl	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Ezetimibe	Ezetimibe	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Propranolol Hcl Er	Propranolol Hcl	14	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Tizanidine Hcl	Tizanidine Hcl	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Colesevelam Hcl	Colesevelam Hcl	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Estradiol	Estradiol	12	suppressed
Fenofibrate	Fenofibrate,micronized	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Mounjaro	Tirzepatide	12	suppressed
Pregabalin	Pregabalin	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Xarelto	Rivaroxaban	12	suppressed
Bethanechol Chloride	Bethanechol Chloride	11	suppressed
Fentanyl	Fentanyl	11	suppressed
Suboxone	Buprenorphine Hcl/Naloxone Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error